Conservest Capital Advisors Inc. Decreases Position in Lam Research Co. (NASDAQ:LRCX)

Conservest Capital Advisors Inc. cut its stake in Lam Research Co. (NASDAQ:LRCX) by 4.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 548 shares of the semiconductor company’s stock after selling 26 shares during the quarter. Conservest Capital Advisors Inc.’s holdings in Lam Research were worth $429,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. PGGM Investments grew its stake in shares of Lam Research by 0.7% in the fourth quarter. PGGM Investments now owns 14,781 shares of the semiconductor company’s stock worth $11,577,000 after acquiring an additional 104 shares during the period. Transcend Capital Advisors LLC bought a new stake in Lam Research during the fourth quarter valued at approximately $710,000. Unique Wealth Strategies LLC bought a new stake in Lam Research during the fourth quarter valued at approximately $759,000. Dohj LLC bought a new stake in Lam Research during the fourth quarter valued at approximately $500,000. Finally, Gilliland Jeter Wealth Management LLC bought a new stake in Lam Research during the fourth quarter valued at approximately $2,017,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Price Performance

Lam Research stock traded up $23.90 during mid-day trading on Friday, reaching $925.37. 1,397,129 shares of the company’s stock traded hands, compared to its average volume of 1,010,097. The company has a market cap of $121.32 billion, a price-to-earnings ratio of 34.03, a PEG ratio of 3.29 and a beta of 1.51. The stock has a 50 day moving average of $943.67 and a two-hundred day moving average of $810.33. The company has a quick ratio of 2.02, a current ratio of 2.82 and a debt-to-equity ratio of 0.56. Lam Research Co. has a 12-month low of $493.42 and a 12-month high of $1,007.39.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, April 24th. The semiconductor company reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.26 by $0.53. The company had revenue of $3.79 billion for the quarter, compared to the consensus estimate of $3.72 billion. Lam Research had a net margin of 25.35% and a return on equity of 45.96%. Lam Research’s revenue was down 2.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.99 earnings per share. Equities analysts forecast that Lam Research Co. will post 29.54 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th were paid a $2.00 dividend. This represents a $8.00 annualized dividend and a dividend yield of 0.86%. The ex-dividend date of this dividend was Tuesday, March 12th. Lam Research’s dividend payout ratio is currently 29.42%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on LRCX shares. JPMorgan Chase & Co. boosted their target price on shares of Lam Research from $900.00 to $950.00 and gave the company an “overweight” rating in a research report on Thursday. UBS Group boosted their target price on shares of Lam Research from $1,130.00 to $1,150.00 and gave the company a “buy” rating in a research report on Thursday. Stifel Nicolaus upped their price target on shares of Lam Research from $950.00 to $1,050.00 and gave the stock a “buy” rating in a research report on Tuesday, April 16th. Mizuho upped their price target on shares of Lam Research from $935.00 to $960.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Susquehanna dropped their price target on shares of Lam Research from $880.00 to $850.00 and set a “neutral” rating for the company in a research report on Thursday. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $950.85.

Insider Activity

In other news, SVP Seshasayee Varadarajan sold 5,500 shares of the stock in a transaction on Monday, March 18th. The shares were sold at an average price of $922.41, for a total value of $5,073,255.00. Following the sale, the senior vice president now owns 22,095 shares of the company’s stock, valued at $20,380,648.95. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, SVP Seshasayee Varadarajan sold 5,500 shares of the stock in a transaction on Monday, March 18th. The shares were sold at an average price of $922.41, for a total value of $5,073,255.00. Following the sale, the senior vice president now owns 22,095 shares of the company’s stock, valued at $20,380,648.95. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CAO Christina Corrreia sold 647 shares of the stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $628,903.41. Following the completion of the sale, the chief accounting officer now directly owns 5,541 shares in the company, valued at approximately $5,386,018.23. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,029 shares of company stock valued at $6,559,489. 0.32% of the stock is currently owned by company insiders.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.